Logo image of ONCE

Onconetix Inc (ONCE) Stock Overview

USA - NASDAQ:ONCE -

113.57 USD
+2.82 (+2.55%)
Last: 12/16/2019, 8:00:01 PM
114.48 USD
+0.91 (+0.8%)
Pre-Market: 12/17/2019, 12:31:45 PM

ONCE Key Statistics, Chart & Performance

Key Statistics
Market Cap4.38B
Revenue(TTM)69.88M
Net Income(TTM)-250447000
Shares38.52M
Float28.00M
52 Week High114.2
52 Week Low34.53
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-6.56
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


ONCE short term performance overview.The bars show the price performance of ONCE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

ONCE long term performance overview.The bars show the price performance of ONCE in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of ONCE is 113.57 USD. In the past month the price increased by 2.49%. In the past year, price increased by 206.86%.

Onconetix Inc / ONCE Daily stock chart

ONCE Latest News, Press Relases and Analysis

About ONCE

Company Profile

Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in Philadelphia, Pennsylvania.

Company Info

Onconetix Inc

3737 MARKET STREET SUITE 1300

PHILADELPHIA PA 19104

CEO: Jeffrey D. Marrazzo

Phone: 888-772-7560

Onconetix Inc / ONCE FAQ

What does ONCE do?

Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in Philadelphia, Pennsylvania.


Can you provide the latest stock price for Onconetix Inc?

The current stock price of ONCE is 113.57 USD. The price increased by 2.55% in the last trading session.


What is the dividend status of Onconetix Inc?

ONCE does not pay a dividend.


What is the ChartMill technical and fundamental rating of ONCE stock?

ONCE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is Onconetix Inc worth?

Onconetix Inc (ONCE) has a market capitalization of 4.38B USD. This makes ONCE a Mid Cap stock.


ONCE Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ONCE. When comparing the yearly performance of all stocks, ONCE is one of the better performing stocks in the market, outperforming 98.44% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ONCE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ONCE. While ONCE seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ONCE Financial Highlights

Over the last trailing twelve months ONCE reported a non-GAAP Earnings per Share(EPS) of -6.56. The EPS decreased by -202.3% compared to the year before.


Industry RankSector Rank
PM (TTM) -358.41%
ROA -35.6%
ROE N/A
Debt/Equity 0.35
Chartmill High Growth Momentum
EPS Q2Q%-36.51%
Sales Q2Q%109.65%
EPS 1Y (TTM)-202.3%
Revenue 1Y (TTM)18.48%

ONCE Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y-151.66%
Revenue Next YearN/A

ONCE Ownership

Ownership
Inst Owners88.37%
Ins Owners82.34%
Short Float %N/A
Short RatioN/A